{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:00:52Z","timestamp":1790006452388,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AR-42309"],"award-info":[{"award-number":["AR-42309"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AR-066418"],"award-info":[{"award-number":["AR-066418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AR-065800"],"award-info":[{"award-number":["AR-065800"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["OD-010945"],"award-info":[{"award-number":["OD-010945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA-060553"],"award-info":[{"award-number":["CA-060553"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.trsl.2016.12.002","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T17:16:02Z","timestamp":1481303762000},"page":"71-86.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1605-3636","authenticated-orcid":false,"given":"Jun","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Bhattachayya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brielle M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Allaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta G.","family":"Marangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren G.","family":"Tourtellotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.12.002_bib1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2016.12.002_bib2","doi-asserted-by":"publisher","first-page":"e0114017","DOI":"10.1371\/journal.pone.0114017","article-title":"Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts","volume":"10","author":"Johnson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.12.002_bib3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1124\/pr.111.004846","article-title":"Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease","volume":"64","author":"Liby","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.trsl.2016.12.002_bib4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/annrheumdis-2012-202716","article-title":"A synthetic PPAR-gamma agonist triterpenoid ameliorates experimental fibrosis: PPAR-gamma-independent suppression of fibrotic responses","volume":"73","author":"Wei","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2016.12.002_bib5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.trsl.2016.12.002_bib6","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ajpath.2016.02.022","article-title":"Nuclear factor-erythroid-2-related factor 2 in aging and lung fibrosis","volume":"186","author":"Swamy","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.12.002_bib7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mam.2011.10.006","article-title":"Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation","volume":"32","author":"Hybertson","year":"2011","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.trsl.2016.12.002_bib8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/ars.2011.4240","article-title":"Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis","volume":"18","author":"Artaud-Macari","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.trsl.2016.12.002_bib9","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.cellsig.2014.07.016","article-title":"MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis","volume":"26","author":"Yang","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.trsl.2016.12.002_bib10","doi-asserted-by":"publisher","first-page":"12936","DOI":"10.1038\/srep12936","article-title":"Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2016.12.002_bib11","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/ndt\/gft022","article-title":"Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy","volume":"28","author":"Aminzadeh","year":"2013","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.trsl.2016.12.002_bib12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1172\/JCI25790","article-title":"Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis","volume":"116","author":"Thimmulappa","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.12.002_bib13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9440(10)63289-0","article-title":"Targeted disruption of TGF-beta\/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma","volume":"165","author":"Lakos","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.12.002_bib14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2353\/ajpath.2009.080574","article-title":"Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma","volume":"174","author":"Wu","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.12.002_bib15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/1523-1747.ep12462561","article-title":"Identification of collagen fibrils in scleroderma skin","volume":"90","author":"Perlish","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.12.002_bib16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"Distler","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2016.12.002_bib17","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1073\/pnas.87.10.3826","article-title":"Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds","volume":"87","author":"Rushmore","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.12.002_bib18","doi-asserted-by":"publisher","first-page":"e8391","DOI":"10.1371\/journal.pone.0008391","article-title":"Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes","volume":"4","author":"Ichikawa","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.12.002_bib19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1097-2765(00)80061-1","article-title":"Human Smad3 and Smad4 are sequence-specific transcription activators","volume":"1","author":"Zawel","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2016.12.002_bib20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/cyto.a.20219","article-title":"An improved method for discrimination of cell populations in tissue sections using microscopy-based multicolor tissue cytometry","volume":"69","author":"Ecker","year":"2006","journal-title":"Cytometry A"},{"key":"10.1016\/j.trsl.2016.12.002_bib21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/art.39061","article-title":"The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor beta signaling","volume":"67","author":"Wei","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2016.12.002_bib22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1465-9921-13-92","article-title":"Gene expression profiling following NRF2 and KEAP1 siRNA knockdown in human lung fibroblasts identifies CCL11\/Eotaxin-1 as a novel NRF2 regulated gene","volume":"13","author":"Fourtounis","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.trsl.2016.12.002_bib23","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2016.12.002_bib24","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1093\/nar\/gkq212","article-title":"Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis","volume":"38","author":"Malhotra","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2016.12.002_bib25","doi-asserted-by":"publisher","first-page":"21592","DOI":"10.1074\/jbc.M300931200","article-title":"Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression","volume":"278","author":"McMahon","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.12.002_bib26","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/jid.2012.479","article-title":"p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-beta: epigenetic feed-forward amplification of fibrosis","volume":"133","author":"Ghosh","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.12.002_bib27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11926-014-0473-0","article-title":"Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis","volume":"17","author":"Piera-Velazquez","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.trsl.2016.12.002_bib28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1874312901206010087","article-title":"New insights into the role of oxidative stress in scleroderma fibrosis","volume":"6","author":"Gabrielli","year":"2012","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.trsl.2016.12.002_bib29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1126\/science.279.5350.537","article-title":"Catalytic galactose oxidase models: biomimetic Cu(II)-phenoxyl-radical reactivity","volume":"279","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.trsl.2016.12.002_bib30","doi-asserted-by":"publisher","first-page":"12731","DOI":"10.1073\/pnas.96.22.12731","article-title":"Nrf2 is essential for protection against acute pulmonary injury in mice","volume":"96","author":"Chan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.12.002_bib31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2016.12.002_bib32","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1021\/jm2002348","article-title":"Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells","volume":"54","author":"Kumar","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.trsl.2016.12.002_bib33","first-page":"2075","article-title":"Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties","volume":"8","author":"Wang","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.trsl.2016.12.002_bib34","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1128\/MCB.24.19.8477-8486.2004","article-title":"The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase","volume":"24","author":"Cullinan","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2016.12.002_bib35","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2016.12.002_bib36","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1042\/BST20150069","article-title":"The Keap1\/Nrf2 pathway in health and disease: from the bench to the clinic","volume":"43","author":"O'Connell","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.trsl.2016.12.002_bib37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"157","author":"Buendia","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2016.12.002_bib38","doi-asserted-by":"publisher","first-page":"E2048","DOI":"10.1073\/pnas.1415111112","article-title":"Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-beta signaling","volume":"112","author":"Oruqaj","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.12.002_bib39","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1096\/fj.04-2591hyp","article-title":"Nrf2, a multi-organ protector?","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2016.12.002_bib40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.freeradbiomed.2011.11.012","article-title":"Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta\/Smad signaling","volume":"52","author":"Oh","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2016.12.002_bib41","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1073\/pnas.0400282101","article-title":"Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid","volume":"101","author":"Suh","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.12.002_bib42","doi-asserted-by":"publisher","first-page":"231ra47","DOI":"10.1126\/scitranslmed.3008182","article-title":"Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance","volume":"6","author":"Hecker","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2016.12.002_bib43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/BOR.0000000000000219","article-title":"Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?","volume":"27","author":"Luckhardt","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.trsl.2016.12.002_bib44","first-page":"972","article-title":"Autophagy and mesenchymal cell fibrogenesis","volume":"1831","author":"Hilscher","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2016.12.002_bib45","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1128\/MCB.00248-10","article-title":"A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62","volume":"30","author":"Lau","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2016.12.002_bib46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.freeradbiomed.2013.07.029","article-title":"Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-beta1 by activating the Nrf2\/ARE pathway in glomerular mesangial cells","volume":"65","author":"Huang","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2016.12.002_bib47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","article-title":"Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis","volume":"75","author":"Zerr","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2016.12.002_bib48","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1101\/gad.237081.113","article-title":"The circadian clock regulates rhythmic activation of the NRF2\/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis","volume":"28","author":"Pekovic-Vaughan","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.trsl.2016.12.002_bib49","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1096\/fj.03-1127fje","article-title":"The transcription factor NRF2 protects against pulmonary fibrosis","volume":"18","author":"Cho","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2016.12.002_bib50","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/labinvest.2008.75","article-title":"The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis","volume":"88","author":"Xu","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2016.12.002_bib51","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1046\/j.1523-1755.2001.00939.x","article-title":"Nrf2-deficient female mice develop lupus-like autoimmune nephritis","volume":"60","author":"Yoh","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2016.12.002_bib52","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2353\/ajpath.2006.051113","article-title":"Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2","volume":"168","author":"Ma","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.12.002_bib53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.12.002_bib54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1586\/17512433.2013.811826","article-title":"Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis","volume":"6","author":"Stangel","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.trsl.2016.12.002_bib55","doi-asserted-by":"publisher","first-page":"e45870","DOI":"10.1371\/journal.pone.0045870","article-title":"Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta\/Smad signaling","volume":"7","author":"Oh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.12.002_bib56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrc3278","article-title":"NRF2 and cancer: the good, the bad and the importance of context","volume":"12","author":"Sporn","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2016.12.002_bib57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-beta and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416304224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416304224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T07:18:28Z","timestamp":1568618308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416304224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":57,"alternative-id":["S1931524416304224"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.12.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}